Cargando…
Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone
OBJECTIVES: Examine whether osteoarthritis (OA) progression can be delayed by halofuginone in anterior cruciate ligament transection (ACLT) rodent models. METHODS: 3-month-old male C57BL/6J (wild type; WT) mice and Lewis rats were randomised to sham-operated, ACLT-operated, treated with vehicle, or...
Autores principales: | Cui, Zhuang, Crane, Janet, Xie, Hui, Jin, Xin, Zhen, Gehua, Li, Changjun, Xie, Liang, Wang, Long, Bian, Qin, Qiu, Tao, Wan, Mei, Xie, Min, Ding, Sheng, Yu, Bin, Cao, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013081/ https://www.ncbi.nlm.nih.gov/pubmed/26470720 http://dx.doi.org/10.1136/annrheumdis-2015-207923 |
Ejemplares similares
-
Halofuginone Attenuates Osteoarthritis by Rescuing Bone Remodeling in Subchondral Bone Through Oral Gavage
por: Mu, Wenbo, et al.
Publicado: (2018) -
Inhibition of TGF–β signaling in subchondral bone mesenchymal stem cells attenuates osteoarthritis
por: Zhen, Gehua, et al.
Publicado: (2013) -
Role of vascular channels as a novel mechanism for subchondral bone damage at cruciate ligament entheses in osteoarthritis and inflammatory arthritis
por: Binks, D A, et al.
Publicado: (2015) -
Parathyroid hormone attenuates osteoarthritis pain by remodeling subchondral bone in mice
por: Sun, Qi, et al.
Publicado: (2021) -
Defactinib attenuates osteoarthritis by inhibiting positive feedback loop between H-type vessels and MSCs in subchondral bone
por: Hu, Yanjun, et al.
Publicado: (2020)